Cobimetinib

Grey

Brand Name(s):Cotellic

Indication:Melanoma-unresectable or metastatic

Rationale:2

Considered:Jan-16

Review Date:Oct-21

Comments:
NICE TA 414
Not recommended for treating unresectable or metastatic melanoma in adults with a BRAF V600 mutation
Oct-21